UCAR-T
Showing 1 - 25 of 8,040
Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell
Recruiting
- Advanced Glioma
- Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
- Targeted IL-13 Rα2 UCAR-T cell injection
- Targeted B7-H3 UCAR-T cell injection
-
Suzhou, Jiangsu, ChinaThe Second Affiliated Hospital of Soochow University
Mar 2, 2023
B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)
Recruiting
- B-Cell Leukemia
- B Cell Lymphoma
- anti-CD19 UCAR-T injection
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Apr 21, 2022
B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- B-ALL
- UCAR-T Cells
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Dec 7, 2022
Peripheral Blood Mononuclear Cell Trial in Suzhou (Peripheral blood mononuclear cell apheresis)
Recruiting
- Peripheral Blood Mononuclear Cell
- Peripheral blood mononuclear cell apheresis
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Nov 3, 2021
B-cell Lymphoma Trial in Kunming (CTA30X UCAR-T injection)
Recruiting
- B-cell Lymphoma
- CTA30X UCAR-T injection
-
Kunming, Yunnan, ChinaNo.212 Daguan Road, Xishan District
Aug 15, 2021
Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma Trial in Hangzhou (CTA101)
Recruiting
- Acute Lymphoblastic Leukemia
- Non-hodgkin Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Dec 24, 2020
T-cell Leukemia, T-cell Lymphoma Trial in ChongQing (CD7 UCAR-T cells, Fludarabine, Cytoxan)
Recruiting
- T-cell Leukemia
- T-cell Lymphoma
- CD7 UCAR-T cells
- +3 more
-
ChongQing, Chongqing, ChinaDepartment of Hematology, Xinqiao Hospital
Jun 21, 2021
B-cell Acute Lymphoblastic Leukemia (B-ALL), Safety and Efficacy of CD19 UCAR-T Cells Trial in Xuzhou (CD19 UCARTcells)
Unknown status
- B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Safety and Efficacy of CD19 UCAR-T Cells
- CD19 UCARTcells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Nov 14, 2019
Peripheral Blood Mononuclear Cell Donation Trial in Nanjing (Peripheral blood mononuclear cell apheresis)
Unknown status
- Peripheral Blood Mononuclear Cell Donation
- Peripheral blood mononuclear cell apheresis
-
Nanjing, Jiangsu, Chinathe First Affiliated Hospital of Nanjing Medical University
Sep 15, 2019
Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)
Recruiting
- Multiple Myeloma
- Plasma Cell Leukemia
- CT0594CP
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Apr 18, 2023
Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)
Recruiting
- Relapsed and/or Refractory Multiple Myeloma
- Plasma Cell Leukemia in Relapse
- Biological
-
Shanghai, Shanghai, ChinaShanghai Tongji Hospital
May 29, 2023
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in ChongQing (anti-CD19 UCAR-T cells, Fludarabine, Cytoxan)
Unknown status
- B-cell Acute Lymphoblastic Leukemia
- B-cell Lymphoma
- anti-CD19 UCAR-T cells
- +3 more
-
ChongQing, Chongqing, ChinaDepartment of Hematology, Xinqiao Hospital
Feb 7, 2020
Hematological Malignancies Trial (Anti-CD7 CAR-T)
Not yet recruiting
- Hematological Malignancies
- Anti-CD7 CAR-T
- (no location specified)
Jul 8, 2022
Attachment Disorder Trial in Malatya (Attachment-Based Intervention Program)
Completed
- Attachment Disorder
- Attachment-Based Intervention Program
-
Malatya, TurkeyEsra Sabanci Baransel
Feb 1, 2023
B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)
Recruiting
- B-cell Non-Hodgkin Lymphoma (B-NHL)
- UCART20x22
- CLLS52
-
Austin, TexasSarah Cannon - St. David South Austin Medical Center
Dec 8, 2022
Collection of Peripheral Blood Mononuclear Cells by Means of Apheresis Trial in Nanjing (collection of peripheral blood
Terminated
- Collection of Peripheral Blood Mononuclear Cells by Means of Apheresis
- collection of peripheral blood mononuclear cells from healthy volunteers
-
Nanjing, Jiangsu, ChinaHematological Department, People's Hospital of Jiangsu Province
Dec 17, 2021
CD19-positive Relapsed or Refractory B-cell Malignancies Trial in Hefei (UTAA09 cells for infusion, Fludarabine,
Not yet recruiting
- CD19-positive Relapsed or Refractory B-cell Malignancies
- UTAA09 cells for infusion
- +2 more
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of USTC (AnHui Provincial Hospital
Oct 13, 2023
Peripheral Blood Mononuclear Cell Trial in Hangzhou (Peripheral blood mononuclear cell apheresis)
Unknown status
- Peripheral Blood Mononuclear Cell
- Peripheral blood mononuclear cell apheresis
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Jun 25, 2020
B-cell Acute Lymphoblastic Leukemia Trial in France, United States (UCART22)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- UCART22
- CLLS52
-
Los Angeles, California
- +10 more
Sep 23, 2022
Cardiomyopathy, Heart Failure, Coronary Artery Disease Trial in Sydney, Berlin, London
Active, not recruiting
- Cardiomyopathy
- +5 more
-
Sydney, New South Wales, Australia
- +3 more
Jun 21, 2022
Pain, Birth, First Trial in Melikgazi (Endorphin massage)
Recruiting
- Pain
- Birth, First
- Endorphin massage
-
Melikgazi, Kayseri, TurkeyErciyes University Faculty of Health Sciences
Mar 1, 2023
Bone Anchored Hearing Implants in Chronic Otitis Media
Recruiting
- Hearing
- Bone-anchored hearing implants
-
Denizli, TurkeyPamukkale University
Sep 20, 2023
B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)
Recruiting
- B-Cell Lymphoblastic Leukemia/Lymphoma
- Anti-CD19 UCAR-NK cells
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022
Pregnancy Related Trial in Malatya (Fetal Heartbeat Monitoring Group)
Not yet recruiting
- Pregnancy Related
- Fetal Heartbeat Monitoring Group
-
Malatya, TurkeyInonu University
Nov 18, 2023
Gallbladder Polyps or Masses Greater Than 8-10 mm in Size Trial in Seoul
Recruiting
- Gallbladder Polyps or Masses Greater Than 8-10 mm in Size
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 28, 2022